Endurant Capital Management’s Clearside Biomedical CLSD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-94,259	Closed	-$580K	–	56
2018 Q3	$580K	Buy	94,259 +64,859	+221%	+$399K	0.26%	62
2018 Q2	$314K	Buy	+29,400	New	+$314K	0.14%	62